LNTH
Price
$90.36
Change
-$6.85 (-7.05%)
Updated
Apr 4, 02:42 PM (EDT)
Capitalization
4.27B
27 days until earnings call
ORGO
Price
$3.82
Change
-$0.25 (-6.14%)
Updated
Apr 4, 02:45 PM (EDT)
Capitalization
374.78M
33 days until earnings call
Ad is loading...

LNTH vs ORGO

Header iconLNTH vs ORGO Comparison
Open Charts LNTH vs ORGOBanner chart's image
Lantheus Holdings
Price$90.36
Change-$6.85 (-7.05%)
Volume$324
Capitalization4.27B
Organogenesis Holdings
Price$3.82
Change-$0.25 (-6.14%)
Volume$200
Capitalization374.78M
LNTH vs ORGO Comparison Chart
Loading...
LNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LNTH vs. ORGO commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LNTH is a Hold and ORGO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (LNTH: $97.21 vs. ORGO: $4.07)
Brand notoriety: LNTH and ORGO are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: LNTH: 82% vs. ORGO: 47%
Market capitalization -- LNTH: $4.27B vs. ORGO: $374.78M
LNTH [@Pharmaceuticals: Other] is valued at $4.27B. ORGO’s [@Pharmaceuticals: Other] market capitalization is $374.78M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LNTH’s FA Score shows that 3 FA rating(s) are green whileORGO’s FA Score has 1 green FA rating(s).

  • LNTH’s FA Score: 3 green, 2 red.
  • ORGO’s FA Score: 1 green, 4 red.
According to our system of comparison, LNTH is a better buy in the long-term than ORGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LNTH’s TA Score shows that 3 TA indicator(s) are bullish while ORGO’s TA Score has 3 bullish TA indicator(s).

  • LNTH’s TA Score: 3 bullish, 5 bearish.
  • ORGO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both LNTH and ORGO are a bad buy in the short-term.

Price Growth

LNTH (@Pharmaceuticals: Other) experienced а +0.18% price change this week, while ORGO (@Pharmaceuticals: Other) price change was -12.85% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.90%. For the same industry, the average monthly price growth was -4.07%, and the average quarterly price growth was -12.01%.

Reported Earning Dates

LNTH is expected to report earnings on May 01, 2025.

ORGO is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-4.90% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LNTH($4.27B) has a higher market cap than ORGO($375M). ORGO has higher P/E ratio than LNTH: ORGO (70.25) vs LNTH (12.93). ORGO YTD gains are higher at: 27.188 vs. LNTH (8.663). LNTH has higher annual earnings (EBITDA): 491M vs. ORGO (36M). LNTH has more cash in the bank: 714M vs. ORGO (104M). ORGO has less debt than LNTH: ORGO (119M) vs LNTH (617M). LNTH has higher revenues than ORGO: LNTH (1.3B) vs ORGO (433M).
LNTHORGOLNTH / ORGO
Capitalization4.27B375M1,138%
EBITDA491M36M1,364%
Gain YTD8.66327.18832%
P/E Ratio12.9370.2518%
Revenue1.3B433M299%
Total Cash714M104M687%
Total Debt617M119M518%
FUNDAMENTALS RATINGS
LNTH vs ORGO: Fundamental Ratings
LNTH
ORGO
OUTLOOK RATING
1..100
6761
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
1891
SMR RATING
1..100
3191
PRICE GROWTH RATING
1..100
4339
P/E GROWTH RATING
1..100
108
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LNTH's Valuation (64) in the Medical Specialties industry is in the same range as ORGO (71) in the Financial Conglomerates industry. This means that LNTH’s stock grew similarly to ORGO’s over the last 12 months.

LNTH's Profit vs Risk Rating (18) in the Medical Specialties industry is significantly better than the same rating for ORGO (91) in the Financial Conglomerates industry. This means that LNTH’s stock grew significantly faster than ORGO’s over the last 12 months.

LNTH's SMR Rating (31) in the Medical Specialties industry is somewhat better than the same rating for ORGO (91) in the Financial Conglomerates industry. This means that LNTH’s stock grew somewhat faster than ORGO’s over the last 12 months.

ORGO's Price Growth Rating (39) in the Financial Conglomerates industry is in the same range as LNTH (43) in the Medical Specialties industry. This means that ORGO’s stock grew similarly to LNTH’s over the last 12 months.

ORGO's P/E Growth Rating (8) in the Financial Conglomerates industry is in the same range as LNTH (10) in the Medical Specialties industry. This means that ORGO’s stock grew similarly to LNTH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LNTHORGO
RSI
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 17 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
74%
N/A
View a ticker or compare two or three
Ad is loading...
LNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CARD8.091.25
+18.27%
Max Auto Industry -3X Inverse Lvrgd ETN
AAA24.92-0.06
-0.22%
Alternative AccessFirstPriorityCLO BdETF
BCAT14.32-0.29
-1.98%
BlackRock Capital Allocation Term Trust
KBWD14.05-0.41
-2.84%
Invesco KBW High Dividend Yld Fincl ETF
LTCN6.49-0.31
-4.61%
Grayscale Litecoin Trust (LTC)

LNTH and

Correlation & Price change

A.I.dvisor tells us that LNTH and ACET have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LNTH and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LNTH
1D Price
Change %
LNTH100%
-0.22%
ACET - LNTH
32%
Poorly correlated
-7.32%
SNDL - LNTH
26%
Poorly correlated
-1.39%
LFCR - LNTH
24%
Poorly correlated
-5.42%
ORGO - LNTH
24%
Poorly correlated
-6.44%
BFRI - LNTH
23%
Poorly correlated
-1.70%
More

ORGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORGO has been loosely correlated with PRGO. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ORGO jumps, then PRGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
-6.44%
PRGO - ORGO
46%
Loosely correlated
-3.62%
ANIP - ORGO
43%
Loosely correlated
-1.54%
AMRX - ORGO
31%
Poorly correlated
-4.41%
ACET - ORGO
29%
Poorly correlated
-7.32%
AMPH - ORGO
27%
Poorly correlated
-2.01%
More